Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
A financial benchmark comprises defined scope, transparent methodology, and objective performance metrics to enable consistent comparison and evaluation.
16,759 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Bagel prices are climbing in 2026, but the bagel remains a daily staple and a symbol of immigrant business resilience...
Andersen Group surged on surprise Q4 strength and an optimistic outlook. This deep dive explains what drove the rally...
As AI data centers surge, the race for reliable, green energy accelerates. This analysis explains how Oklo could beco...
Evernorth has filed Form S-4 as it advances a merger with Armada Acquisition Corp. II to take a Nasdaq-listed XRP tre...
A large insider purchase by Conagra's CEO has investors buzzing. Learn what insider buying signals really mean, how t...
Uber unveils a multiyear pact to invest up to $1.25 billion in Rivian, aiming to roll out up to 50,000 autonomous Riv...
Major League Baseball announces a formal partnership with Polymarket and an integrity pact with the CFTC to guide pre...
Broadcom has unveiled the world’s first quantum-safe encryption embedded in silicon, a milestone that could reorder e...
A multibillion-dollar air defense push in Greece is drawing investor attention to Lockheed Martin and other defense c...
A major defense modernization program in Greece, nicknamed the Achilles Shield, signals long-term military procuremen...
Rental-focused development dominated Q4 2025, with 91,000 rental starts among 96,000 total multifamily starts, a jump...